EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Empagliflozin Prevents Cardiac Arrest-Induced Renal Injury Through BHB-Dependent Mitoribosome Maintenance

Kazuhiro Hasegawa iD, Masanori Tamaki iD, Sumiyo Yamaguchi, Ikuko Shimizu, Takahiro Kida, Shinji Miyakami, Miho Tada, Chihiro Okinari, Makoto Otsuka, Masanori Minato, Shu Wakino

International Journal of Molecular Sciences · 17.07.2026 · 27 (14) · 6366

DOI: 10.3390/ijms27146366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.07.2026. Verfasst von Kazuhiro Hasegawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan. Hauptthemen laut MEDLINE: Glucosides, Acute Kidney Injury, 3-Hydroxybutyric Acid, Benzhydryl Compounds. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac arrest followed by cardiopulmonary resuscitation (CA/CPR) induces systemic ischemia and frequently results in acute kidney injury (AKI). The ketone body β-hydroxybutyrate (BHB) maintains mitochondrial and peroxisomal homeostasis through activation of the C/EBPβ–Pck1 axis, whereas Pck1 preserves mitoribosome integrity and mtDNA-encoded oxidative phosphorylation (OXPHOS) translation. However, it remains unclear whether this pathway is disrupted during CA/CPR-induced AKI and whether empagliflozin can restore its activity. Male C57BL/6J mice and proximal tubule-specific Pck1 conditional knockout (CKO) mice were subjected to short-duration or standard CA/CPR protocols. Empagliflozin was administered orally for 7 days before CA/CPR induction. Circulating BHB levels, renal expression of C/EBPβ and Pck1, and markers of mitochondrial, peroxisomal, and mitoribosomal abundance and function were evaluated using established methods. CA/CPR markedly reduced circulating BHB levels and suppressed the C/EBPβ–Pck1 signaling axis. These changes were accompanied by depletion of peroxisomal markers, mitochondrial regulators, and mitoribosomal components as well as increased tubular apoptosis and albuminuria. Pck1 CKO mice exhibited severe organelle dysfunction and aggravated renal injury. In contrast, empagliflozin restored BHB levels, preserved C/EBPβ and Pck1 expression, and maintained mitochondrial, peroxisomal, and mitoribosomal integrity, thereby attenuating tubular injury and albuminuria. Notably, empagliflozin treatment increased BHB, C/EBPβ, and Pck1 levels in noninjured mice without inducing organelle expansion, suggesting that Pck1 activation alone is insufficient to promote mitoribosome biogenesis under basal conditions. Collectively, these findings demonstrate that empagliflozin protects against CA/CPR-induced AKI and identify Pck1 as a key metabolic regulator linking ketone signaling to organelle resilience.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucosidesAcute Kidney Injury3-Hydroxybutyric AcidBenzhydryl CompoundsHeart ArrestAnimalsMaleMiceMice, KnockoutMitochondriaMice, Inbred C57BLKidney Tubules, ProximalCardiopulmonary ResuscitationSignal Transduction

Stichwörter der Autor:innen

cardiac arrest-induced acute kidney injuryempagliflozinβ-hydroxybutyrate

Substanzen

Glucosidesempagliflozin3-Hydroxybutyric AcidBenzhydryl Compounds

Autor:innen und Institutionen

  • Department of Nephrology, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

ORCID-Profile: Kazuhiro Hasegawa, Masanori Tamaki

Förderung

  • Boehringer Ingelheim

Zitieren

APA

Hasegawa, K., Tamaki, M., Yamaguchi, S., Shimizu, I., Kida, T., Miyakami, S., Tada, M., Okinari, C., Otsuka, M., Minato, M., & Wakino, S. (2026). Empagliflozin Prevents Cardiac Arrest-Induced Renal Injury Through BHB-Dependent Mitoribosome Maintenance. International Journal of Molecular Sciences, 27(14), 6366. https://doi.org/10.3390/ijms27146366

Vancouver

Hasegawa K, Tamaki M, Yamaguchi S, Shimizu I, Kida T, Miyakami S, et al. Empagliflozin Prevents Cardiac Arrest-Induced Renal Injury Through BHB-Dependent Mitoribosome Maintenance. International Journal of Molecular Sciences. 2026;27(14):6366. doi:10.3390/ijms27146366

BibTeX
@article{Hasegawa2026,
  author = {Hasegawa, Kazuhiro and Tamaki, Masanori and Yamaguchi, Sumiyo and Shimizu, Ikuko and Kida, Takahiro and Miyakami, Shinji and Tada, Miho and Okinari, Chihiro and Otsuka, Makoto and Minato, Masanori and Wakino, Shu},
  title = {Empagliflozin Prevents Cardiac Arrest-Induced Renal Injury Through BHB-Dependent Mitoribosome Maintenance},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6366},
  doi = {10.3390/ijms27146366}
}
Kostenlos starten →